1887

Abstract

The human cytomegalovirus-encoded protein kinase pUL97 is a determinant of efficient virus replication and fulfils several regulatory functions. In particular, pUL97 interacts with and phosphorylates viral and cellular proteins. Substrate phosphorylation has regulatory consequences on viral replicative stages such as DNA synthesis, transcription and nuclear capsid egress. pUL97, in accordance with related herpesviral protein kinases, possesses strong autophosphorylation activity. Here, we demonstrate that pUL97 shows a pronounced potential to self-interact. Self-interaction of pUL97 is not dependent on its kinase activity, as seen with a catalytically inactive point mutant. The property of self-interaction maps to the amino acid region 231–280 which is separable from the postulated kinase domain. The detection of high-molecular-mass complexes of pUL97 suggests the formation of dimers and oligomers. Importantly, the analysis of pUL97 mutants by kinase assays demonstrated a correlation between self-interaction and protein kinase activity, i.e. all mutants lacking the ability to self-interact were negative or reduced in their kinase activity. Thus, our findings provide novel insights into the pUL97 structure–activity relationship suggesting an importance of self-interaction for pUL97 functionality.

Loading

Article metrics loading...

/content/journal/jgv/10.1099/vir.0.82393-0
2007-02-01
2024-03-29
Loading full text...

Full text loading...

/deliver/fulltext/jgv/88/2/395.html?itemId=/content/journal/jgv/10.1099/vir.0.82393-0&mimeType=html&fmt=ahah

References

  1. Allen G. S., Steinhauer K., Hillen W., Stulke J., Brennan R. G. 2003; Crystal structure of HPr kinase/phosphatase from Mycoplasma pneumoniae . J Mol Biol 326:1203–1217 [CrossRef]
    [Google Scholar]
  2. Baek M. C., Krosky P., Coen D. M. 2002; Relationship between autophosphorylation and phosphorylation of exogenous substrates by the human cytomegalovirus UL97 protein kinase. J Virol 76:11943–11952 [CrossRef]
    [Google Scholar]
  3. Biron K. K., Harvey R. J., Chamberlain S. C., Good S. S., Smith A. A. III, Davis M. G., Talarico C. L., Miller W. H., Ferris R. other authors 2002; Potent and selective inhibition of human cytomegalovirus replication by 1263W94, a benzimidazole l-riboside with a unique mode of action. Antimicrob Agents Chemother 46:2365–2372 [CrossRef]
    [Google Scholar]
  4. Chee M. S., Lawrencem G. L., Barrell B. G. 1989; Alpha-, beta- and gammaherpesviruses encode a putative phosphotransferase. J Gen Virol 70:1151–1160 [CrossRef]
    [Google Scholar]
  5. El-Battari A., Prorok M., Angata K., Methieu S., Zerfaoui M., Ong E., Suzuki M., Lombardo D., Fukuda M. 2003; Different glycosyltransferases are differentially processed for secretion, dimerization, and autoglycosylation. Glycobiology 13:941–953 [CrossRef]
    [Google Scholar]
  6. Gramberg T., Zhu T., Chaipan C., Marzi A., Liu H., Wegele A., Andrus T., Hofman H., Pöhlmann S. 2006; Impact of polymorphisms in the DC-SIGNR neck domain on the interaction with pathogens. Virology 347:354–363 [CrossRef]
    [Google Scholar]
  7. He Z., He Y. S., Kim Y., Chu L., Ohmstede C., Biron K. K., Coen D. M. 1997; The human cytomegalovirus UL97 protein is a protein kinase that autophosphorylates on serines and threonines. J Virol 71:405–411
    [Google Scholar]
  8. Herget T., Freitag M., Morbitzer M., Stamminger T., Marschall M. 2004; A novel chemical class of pUL97 protein kinase-specific inhibitors with strong anti-cytomegaloviral activity. Antimicrob Agents Chemother 48:4154–4162 [CrossRef]
    [Google Scholar]
  9. Honegger A. M., Schmidt A., Ullrich A., Schlessinger J. 1990; Evidence for epidermal growth factor (EGF)-induced intermolecular autophosphorylation of the EGF receptors in living cells. Mol Cell Biol 10:4035–4044
    [Google Scholar]
  10. Johnson D. A., Akamine P., Radzio-Andzelm E., Madhusudan M., Taylor S. S. 2001; Dynamics of cAMP-dependent protein kinase. Chem Rev 101:2243–2270 [CrossRef]
    [Google Scholar]
  11. Jorissen R. N., Walker F., Pouliot N., Garrett T. P. J., Ward C. W., Burgess A. W. 2003; Epidermal growth factor receptor: mechanisms of activation and signalling. Exp Cell Res 284:31–53 [CrossRef]
    [Google Scholar]
  12. Kostura M., Mathews M. B. 1989; Purification and activation of the double-stranded RNA-dependent eIF-2 kinase DAI. Mol Cell Biol 9:1576–1586
    [Google Scholar]
  13. Krosky P. M., Baek M.-C., Coen D. M. 2003a; The human cytomegalovirus UL97 protein kinase, an antiviral drug target, is required at the stage of nuclear egress. J Virol 77:905–914 [CrossRef]
    [Google Scholar]
  14. Krosky P. M., Baek M.-C., Jahng W. J., Barrera I., Harvey R. J., Biron K. K., Coen D. M., Sethna P. B. 2003b; The human cytomegalovirus UL44 protein is a substrate for the UL97 protein kinase. J Virol 77:7720–7727 [CrossRef]
    [Google Scholar]
  15. Liu W., Tang L., Zhang G., Wei H., Cui Y., Guo L., Gou Z., Chen X., Jiang D. other authors 2004; Characterization of a novel C-type lectin-like gene, LSECtin. J Biol Chem 279:18748–18758 [CrossRef]
    [Google Scholar]
  16. Marschall M., Stein-Gerlach M., Freitag M., Kupfer R., van den Bogaard M., Stamminger T. 2001; Inhibitors of human cytomegalovirus replication drastically reduce the activity of the viral protein kinase pUL97. J Gen Virol 82:1439–1450
    [Google Scholar]
  17. Marschall M., Stein-Gerlach M., Freitag M., Kupfer R., van den Bogaard M., Stamminger T. 2002; Direct targeting of human cytomegalovirus protein kinase pUL97 by kinase inhibitors is a novel principle of antiviral therapy. J Gen Virol 83:1013–1023
    [Google Scholar]
  18. Marschall M., Freitag M., Suchy P., Romaker D., Kupfer R., Hanke M., Stamminger T. 2003; The protein kinase pUL97 of human cytomegalovirus interacts with and phosphorylates the DNA polymerase processivity factor pUL44. Virology 311:60–71 [CrossRef]
    [Google Scholar]
  19. Marschall M., Marzi A., aus dem Siepen P., Jochmann R., Kalmer M., Auerochs S., Lischka P., Leis M., Stamminger T. 2005; Cellular p32 recruits cytomegalovirus kinase pUL97 to redistribute the nuclear lamina. J Biol Chem 280:33357–33367 [CrossRef]
    [Google Scholar]
  20. Michel D., Papic I., Zimmermann A., Haupt E., Wunderlich K., Heuschmid M., Mertens T. 1996; The UL97 gene product of human cytomegalovirus is an early-late protein with a nuclear localization but is not a nucleoside kinase. J Virol 70:6340–6346
    [Google Scholar]
  21. Michel D., Kramer S., Höhn S., Schaarschmidt P., Wunderlich K., Mertens T. 1999; Amino acids of conserved kinase motifs of cytomegalovirus protein UL97 are essential for autophosphorylation. J Virol 73:8898–8901
    [Google Scholar]
  22. Prichard M. N., Gao N., Jairath S., Mulamba G., Krosky P., Coen D. M., Parker B. O., Pari G. S. 1999; A recombinant human cytomegalovirus with a large deletion in UL97 has a severe replication deficiency. J Virol 73:5663–5670
    [Google Scholar]
  23. Romaker D., Stamminger T., Marschall M. 2004; Comparative analysis of alpha-, beta- and gamma-herpesviral protein kinases (UL97 subgroup). In Abstracts of the Annual Meeting of the German Society of Virology (GfV) Tübingen, Germany:
    [Google Scholar]
  24. Romaker D., Schregel V., Maurer K., Auerochs S., Marzi A., Sticht H., Marschall M. 2006; Analysis of the structure–activity relation of four UL97 subfamily herpesviral protein kinases reveals partial but not full functional conservation. J Med Chem 49:7044–7053 [CrossRef]
    [Google Scholar]
  25. Schregel V., Romaker D., Maurer K., Auerochs S., Stamminger T., Sticht H., Marschall M. 2005; Distinct functional conservation among herpesviral protein kinases of the UL97 subfamily. In Abstracts of the 30 International Herpesvirus Workshop Turku, Finland:
    [Google Scholar]
  26. van Zeijl M., Fairhurst J., Baum E. Z., Sun L., Jones T. R. 1997; The human cytomegalovirus UL97 protein is phosphorylated and a component of virions. Virology 231:72–80 [CrossRef]
    [Google Scholar]
  27. Wang L. H., Peck R. W., Yin Y., Allanson J., Wiggs R., Wire M. B. 2003; Phase I safety and pharmacokinetic trials of 1263W94, a novel oral anti-human cytomegalovirus agent, in healthy and human immunodeficiency virus-infected subjects. Antimicrob Agents Chemother 47:1334–1342 [CrossRef]
    [Google Scholar]
  28. Williams B. R. 1999; PKR; a sentinel kinase for cellular stress. Oncogene 18:6112–6120 [CrossRef]
    [Google Scholar]
  29. Wolf D. G., Honigman A., Lazarovits J., Tavor E., Panet A. 1998; Characterization of the human cytomegalovirus UL97 gene product as a virion-associated protein kinase. Arch Virol 143:1223–1232 [CrossRef]
    [Google Scholar]
  30. Wolf D. G., Courcelle C. T., Prichard M. N., Mocarski E. S. 2001; Distinct and separate roles for herpesvirus-conserved UL97 kinase in cytomegalovirus DNA synthesis and encapsidation. Proc Natl Acad Sci U S A 98:1895–1900 [CrossRef]
    [Google Scholar]
http://instance.metastore.ingenta.com/content/journal/jgv/10.1099/vir.0.82393-0
Loading
/content/journal/jgv/10.1099/vir.0.82393-0
Loading

Data & Media loading...

This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error